This HTML5 document contains 152 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n11http://dx.doi.org/10.1054/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q28352371
rdf:type
wikibase:Item
schema:description
tieteellinen artikkeli artículu científicu espublizáu en 2001 2001年论文 2001年论文 artikull shkencor articolo scientifico научна статия 2001年論文 επιστημονικό άρθρο tudományos cikk سائنسی مضمون 2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված artigo científico article scientifique (publié 2001) 2001年論文 научни чланак 2001年论文 2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած სამეცნიერო სტატია мақолаи илмӣ scienca artikolo מאמר מדעי videnskabelig artikel (udgivet 2001) 2001 nî lūn-bûn vědecký článek publikovaný v roce 2001 2001年論文 vetenskaplig artikel vitskapeleg artikkel мақолаи илмӣ научни чланак 2001年論文 scientific article ২০০১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ articol științific wetenschappelijk artikel (gepubliceerd op 2001/09/14) 2001年论文 2001年论文 article scientific bài báo khoa học บทความทางวิทยาศาสตร์ 2001년 논문 artigo científico (publicado na 2001) наукова стаття, опублікована у вересні 2001 artículo científico publicado en 2001 wissenschaftlicher Artikel مقالة علمية (نشرت في 14-9-2001) artikulong pang-agham vitenskapelig artikkel vedecký článok (publikovaný 2001/09/14) naučni članak teaduslik artikkel artigo científico (publicado na 2001) научная статья 2001年論文 2001年の論文 article científic mokslinis straipsnis مقالهٔ علمی bilimsel makale 2001年论文 artykuł naukowy
p:P577
wds:Q28352371-C2E3D04E-E0F1-4C8E-BFBC-6538D2547610
wdt:P577
2001-09-01T00:00:00Z
p:P407
wds:Q28352371-A66A7043-6FB1-4643-96E2-D0903C3C56B3
wdt:P407
wd:Q1860
p:P2860
wds:Q28352371-025CDBB4-AE4A-4E92-AD40-6FE41C19C346 wds:Q28352371-DC43A359-D90E-45E5-80E2-36B71E29DC4B wds:Q28352371-EB65F2F7-7B24-4B5B-BBB2-617C918D4F45 wds:Q28352371-99DD2444-8AE5-42DB-9409-FA1D60D1C107 wds:Q28352371-772003E4-CD2D-41F5-BDD4-FEC82B7099FE wds:Q28352371-8C722065-B30A-4A59-A297-6B833271CA96 wds:Q28352371-2B194ACA-2259-4425-9C09-51252D45CD22 wds:Q28352371-408DAB52-6822-41AD-811A-43164708B22D wds:Q28352371-265BE5BA-33E3-481A-A5B8-66BBEB9E1FB2 wds:Q28352371-5CA8049E-008F-4F7D-88EA-B0218B0BE34E wds:Q28352371-73924198-02E2-401F-8E74-248183798302 wds:Q28352371-68D3E10F-DBCA-4287-9179-048FCDCA85B9 wds:Q28352371-541B41D2-D485-4A02-93D3-1ED61A8D7375
wdt:P2860
wd:Q44583571 wd:Q54156953 wd:Q68920718 wd:Q36079497 wd:Q42276782 wd:Q25938997 wd:Q40945566 wd:Q33328282 wd:Q68532626 wd:Q54346704 wd:Q44699885 wd:Q73494763 wd:Q72082642
p:P2093
wds:Q28352371-1BAB3873-889E-4B25-9984-203687E7B82C wds:Q28352371-4ADF31AF-188D-4AC8-BF73-06C2C87234C8 wds:Q28352371-4A22C86F-4451-4B99-8096-85E005321284 wds:Q28352371-A07C62BF-612F-4DCF-9738-285AE038E257 wds:Q28352371-C3DD31F1-764F-4CA9-A1D9-CC00644B7A5A wds:Q28352371-C0239C9A-0833-4923-980B-4FA97C04E1C9 wds:Q28352371-C8A10274-EDF8-4790-9853-EB7E212283E7 wds:Q28352371-EDF833C7-264D-493B-B3B4-904EF890EC68 wds:Q28352371-E5121E7D-98B8-4714-9055-7427410B8B8A
wdt:P2093
V Georgoulias L Vamvakas D Mavroudis S Kakolyris J Souglakos C Kouroussis K Kalbakis S Agelaki M Christodoulakis
rdfs:label
Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthra Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with [...]
skos:prefLabel
Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with [...] Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthra
schema:name
Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with [...] Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthra
p:P50
wds:Q28352371-87112A16-46D4-4BA2-A3D8-93AAB87C01C7
wdt:P50
wd:Q50856634
p:P1476
wds:Q28352371-67AAE60D-46D1-4072-BB93-F34EF245CADD
wdt:P1476
Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanes
p:P304
wds:Q28352371-37C441C3-0CFC-4017-BDCF-9B6E317F883A
wdt:P304
798-802
p:P31
wds:Q28352371-1A6E85DC-2366-4268-95DA-5EAEEFB5B0C9
wdt:P31
wd:Q13442814
p:P921
wds:Q28352371-D33882D7-0530-4BF3-8A8C-5765C7A5FACE wds:Q28352371-7C7A53AA-3996-473E-B87A-AA24527762D4
wdt:P921
wd:Q12859063 wd:Q238512
p:P698
wds:Q28352371-D2ED38BE-E45C-4065-AAFF-466AE600C046
wdtn:P698
n10:11556827
wdt:P698
11556827
p:P1433
wds:Q28352371-BED51280-B9BE-4DE9-A824-37D760055A22
wdt:P1433
wd:Q326309
p:P433
wds:Q28352371-CD9F0C82-AA80-4EA2-81CC-0182666E1E70
p:P478
wds:Q28352371-EE7D3C91-00F1-44C0-AAAC-4CE1A86D39ED
wdt:P433
6
wdt:P478
85
p:P356
wds:Q28352371-FBE414E9-BC0C-4116-8A43-1B71AE36805B
wdtn:P356
n11:BJOC.2001.2001
wdt:P356
10.1054/BJOC.2001.2001
p:P275
wds:Q28352371-ac970393-8383-4bbc-938d-798143cecdc3
p:P6216
wds:Q28352371-21783788-84eb-40c4-9845-924d9dc57625
wdt:P275
wd:Q15643954
wdt:P6216
wd:Q50423863
p:P5875
wds:Q28352371-BC47EB46-E421-4AA1-8A88-08EB5C6C234E
wdt:P5875
11790718
p:P10863
wds:Q28352371-3CE09B52-271D-421F-B427-D46DDC047E2C
p:P6179
wds:Q28352371-092B360B-3C3C-473E-AD6B-2A43E963B1B3
wdt:P10863
10.1054/bjoc.2001.2001
wdt:P6179
1022213949
p:P932
wds:Q28352371-45FC47BE-3D29-4FFF-9DB4-527AAF375695
wdt:P932
2375071